| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 12/27/2006 | EP1735312A1 Substituted diaza-spiro-[5.5|-undecane derivatives and their use as neurokinin antagonists |
| 12/27/2006 | EP1735311A1 Beta-carbolines useful for treating inflammatory disease |
| 12/27/2006 | EP1735310A1 Condensed pyridine derivatives useful as a28 adenosine receptor antagonists |
| 12/27/2006 | EP1735309A1 An improved process for the preparation of n-([1,2,4]triazolopyrimidin-2-yl)aryl sulfonamides |
| 12/27/2006 | EP1735308A1 Fused ring azadecalin glucocorticoid receptor modulators |
| 12/27/2006 | EP1735307A1 Inhibitors of iap |
| 12/27/2006 | EP1735270A1 Diamino alcohols and their use as renin inhibitors |
| 12/27/2006 | EP1734966A2 Piperizinylpiperidine derivatives as chemokine receptor antagonists |
| 12/27/2006 | EP1734951A2 Diphenyl-indol-2-on compounds and their use in the treatment of cancer |
| 12/27/2006 | EP1734820A2 Imidazopyrazines, imidazopyridines, and imidazopyrimidines as crf1 receptor ligands |
| 12/27/2006 | EP1608317A4 Dipeptidyl peptidase inhibitors |
| 12/27/2006 | EP1554259B1 Novel bicyclic inhibitors of hormone sensitive lipase |
| 12/27/2006 | EP1443925B1 Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors |
| 12/27/2006 | EP1404704B1 Bridged bicyclic serine protease inhibitors |
| 12/27/2006 | EP1381604B1 Amyloid plaque aggregation inhibitors and diagnostic imaging agents |
| 12/27/2006 | EP1149118B1 Method of producing derivatized polymers |
| 12/27/2006 | CN1886421A Hemiasterlin derivatives and uses thereof |
| 12/27/2006 | CN1886407A Bicyclic pyrazolyl and imidazolyl compounds and uses thereof |
| 12/27/2006 | CN1886402A pyrimidin-2-amine derivates and their use as a2b adenosine receptor antagonists |
| 12/27/2006 | CN1886386A Phenylene derivative having tetrazole ring or thiazolidinedione ring |
| 12/27/2006 | CN1291995C **Tc marked dopamine transport protein developer |
| 12/27/2006 | CN1291988C Triazaspiro [5,5] undecane derivatrives and drugs containing the same as active ingredient |
| 12/27/2006 | CN1291987C Process for preparing acid salts of gemifloxacin |
| 12/27/2006 | CN1291983C Luminescent element material and luminescent element comprising the same |
| 12/26/2006 | US7153969 Coupling methyl (R)-2-(R1OSO2)-2-(2-chlorophenyl)acetates with 2-(thien-2-yl)ethylamine, concurrent or successive formylation and cyclization to form methyl (S)-2(2-chlorophenyl)-2-(4,5,6,7-tetrahydrothieno[3,2-c]-5-pyridyl)acetate (clopidrogrel) |
| 12/26/2006 | US7153968 For therapy of asthma, chronic bronchitis, chronic obstructive pulmonary disease, eosinophilic granuloma, psoriasis and other benign or malignant proliferative skin diseases, endotoxic shock, laminitis in horses, colic in horses, septic shock, ulcerative colitis, Crohn's disease, reperfusion injury |
| 12/26/2006 | US7153967 Preparation of 1H-imidazo [4,5-C] quinolin-4-amines via 1H-imidazo [4,5-C] quinolin-4-phthalimide intermediates |
| 12/26/2006 | US7153964 Pyrimidine compounds |
| 12/26/2006 | US7153963 Phenylalanine derivatives |
| 12/26/2006 | US7153960 Synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones |
| 12/26/2006 | US7153959 treatment of tumor necrosis factor mediated disorders; asthma; inflammatory bowel disease; arthritis |
| 12/26/2006 | US7153889 Alzheimer's disease; antihistamines; attention deficit disorders; hyperactivity; bipolar disorders; cognition activators; psychological disorders; anticancer agents; antidepressants; antiepileptic agents; gastrointestinal disorders ; analgesics |
| 12/26/2006 | US7153882 (Aminocarbonyloxy)-benzofused ring derivatives; Alzheimer*s disease; neurodegenerative disorders |
| 12/26/2006 | US7153873 E.g., 7-acetyl-5-tert-butylamino-6-phenyl-imidazo[2,1-b]-thiazol-7-ium chloride; treatment of pain, diarrhea, urinary incontinence, depression, and anxiety |
| 12/26/2006 | US7153872 Cancer and fibrotic diseases |
| 12/26/2006 | US7153863 Therapeutic compounds based on pyrazolopyridline derivatives |
| 12/26/2006 | US7153862 αv integrin receptor antagonists |
| 12/26/2006 | US7153860 5-Phenylpyrimidines, methods and intermediate products for the production thereof and use of the same for controlling pathogenic fungi |
| 12/26/2006 | US7153859 For prophylaxis and therapy of asthma, chronic obstructive pulmonary disease, chronic bronchitis, atopic dermatitis, urticaria, allergic rhinitis, allergic conjunctivitis, vernal conjunctivitis, eosinophilia, psoriasis, rheumatoid arthritis, septic shock, ulcerative colitis, Crohn's disease |
| 12/26/2006 | US7153856 Orally administering N-(2-chloro-6-methylphenyl)-2-[4-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-6-ylamino]thiazole-5-carboxamide for treating cancer |
| 12/26/2006 | US7153855 Pyrazolopyridinyl pyrimidine therapeutic compounds |
| 12/26/2006 | US7153847 Dipeptide-substituted benzo- and dibenzocaprolactams, which inhibit beta -amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease |
| 12/21/2006 | WO2006135826A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 12/21/2006 | WO2006135795A1 Imidazo- and triazolopyridines as inhibitors of 11-beta hydroxysteroid dehydrogenase type i |
| 12/21/2006 | WO2006135667A1 Imidiazo -and triazolopyridines as inhibitors of 11-beta hydroxysteroid dehydrogenase type i |
| 12/21/2006 | WO2006135343A1 Detectable threading intercalator |
| 12/21/2006 | WO2006134491A2 New crystalline form of moxifloxacin hydrochloride and process for its preparation |
| 12/21/2006 | WO2006134431A1 Formate salt of gemifloxacin |
| 12/21/2006 | WO2006134112A1 Spiro-imidaznaphthyridine derivatives as gastric acid secretion inhibitors |
| 12/21/2006 | WO2006134111A1 Spiro-benzimidazoles as inhibitors of gastric acid secretion |
| 12/21/2006 | WO2006133869A1 Process for the preparation of 3,7-diazabicyclo[3.3.1]nonane compounds |
| 12/21/2006 | WO2006133821A1 Tetrahydroquinolines used in the form of modulators of mitotic motor-proteins eg5 |
| 12/21/2006 | WO2006133588A1 ARYL UREA COMPOUNDS AS β-SECRETASE INHIBITORS |
| 12/21/2006 | WO2006092599A3 Pyrrole derivatives as dna gyrase and topoisomerase inhibitors |
| 12/21/2006 | WO2006076569A3 Bicyclic heterocycles as cannabinoid receptor modulators |
| 12/21/2006 | WO2006070408A3 A process for the preparation of substantially pure 4-amino-1-isobutyl-1h-imidazo[4,5-c]-quinoline (imiquimod) |
| 12/21/2006 | WO2006058303A3 Modulators of muscarinic receptors |
| 12/21/2006 | WO2005092856A8 Tetrahydrocarbazoles and derivatives |
| 12/21/2006 | US20060287531 antiviral for HIV and AIDS; N-(1-Benzoyl-pyrrolidin-3-ylmethyl)-2-(4-fluoro-1H-indol-3-yl)-2-oxo-acetamide; N-(1-Benzoyl-pyrrolidin-3-ylmethyl)-2-oxo-2-(1H-pyrrolo[2,3-b]pyridin-3-yl)-acetamide |
| 12/21/2006 | US20060287357 Compounds are substituted 8-phenoxy-3-(bicyclo)alkyl-1,2,4-triazolo(4,3-a)pyridines; diabetes, hyperglycemia, obesity, dyslipidemia, hypertension, cognitive impairment, rheumatoid arthritis, glaucoma |
| 12/21/2006 | US20060287355 Imidazo and thiazolopyridines as jak3 kinase inhibitors |
| 12/21/2006 | US20060287354 Azaindole compounds as kinase inhibitors |
| 12/21/2006 | US20060287349 Benzimidazolyl- or N-hetero analog derivatives of 4-aza-5 alpha -androstan-3-ones, e.g., beta -(1H-imidazo[4,5-c]pyridin-2-yl)-4-methyl-4-aza-5 alpha -androst-1-en-3-one; treatment of conditions caused by androgen deficiency |
| 12/21/2006 | US20060287324 6-(2-Chlorophenyl)-7-(4-chlorophenyl)-N-cyclohexyl-[1,2,4]triazolo[4,3-b]pyridazin-3-amine; drug abuse, drug dependency; smoking cigarettes; appetite suppressants; antilipemic agents; anticholesterol agents; increasing high density lipoproteins;hypotensive agents; antidiabetic agents |
| 12/21/2006 | US20060287310 7-[4-(4-naphthalen-1-yl-piperazin-1-yl)-butoxy]-3,4-dihydro-1H-[1,8]naphthyridin-2-one; use in the treatment of central nervous system disorders, bipolar disorder in a human; chemical synthesis |
| 12/21/2006 | US20060287309 [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia |
| 12/21/2006 | US20060287308 3-Aminoquinazolin-2,4-dione antibacterial agents |
| 12/21/2006 | US20060287307 Antibacterial compounds |
| 12/21/2006 | US20060287292 Histamine H3 receptor and serotonin transporter modulators; 4-(2-fluoro-phenyl)-7-(3-piperidin-1-yl-propoxy)-1,2,3,4-tetrahydro-[2,6]naphthyridine |
| 12/21/2006 | US20060287290 Azabicyclic compounds are central nervous system active agents |
| 12/21/2006 | US20060286408 1,8-Naphthyridine compound and organic light-emitting device using the same |
| 12/21/2006 | US20060286043 Delivery of antihistamines through an inhalation route |
| 12/21/2006 | US20060286042 Condensation aerosol for delivery of a drug selected from the group consisting of zaleplon, zolpidem and zopiclone |
| 12/21/2006 | CA2627589A1 Spiro-benzimidazoles as inhibitors of gastric acid secretion |
| 12/21/2006 | CA2611893A1 Tetrahydroquinolines for use as modulators of the mitotic motor protein eg5 |
| 12/21/2006 | CA2611529A1 Imidazo- and triazolopyridines as inhibitors of 11-beta hydroxysteroid dehydrogenase type i |
| 12/21/2006 | CA2610920A1 Spiro-imidaznaphthyridine derivatives as gastric acid secretion inhibitors |
| 12/21/2006 | CA2610588A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 12/20/2006 | EP1734040A1 Substituted quinazoline or pyridopyrimidine derivative |
| 12/20/2006 | EP1734039A1 Aryl urea compounds as BETA-secretase inhibitors |
| 12/20/2006 | EP1733161A1 Device and method for pneumatic valve control |
| 12/20/2006 | EP1732935A2 Lanthanide chelates and use thereof in bioanalysis |
| 12/20/2006 | EP1732933A1 Compounds and methods for treating dyslipidemia |
| 12/20/2006 | EP1732928A2 Alpha aryl or heteroaryl methyl beta piperidino propanoic acid compounds as orl1-receptor antagonists |
| 12/20/2006 | EP1732926A1 Mitotic kinesin inhibitors |
| 12/20/2006 | EP1732925A1 Novel n-(alkoxyalkyl)carbamoyl- substituted 6-phenyl-benzonaphthyridine derivatives and their use as pde3/4 inhibitors |
| 12/20/2006 | EP1732924A2 Tetrahydronaphthyridine derivatives as cholesteryl ester transfer protein inhibitors |
| 12/20/2006 | EP1732893A2 Alpha aryl or heteroaryl methyl beta piperidino propanamide compounds as orl1-receptor antagonist |
| 12/20/2006 | EP1732892A1 Tetrahydrocarbazoles and derivatives |
| 12/20/2006 | EP1732887A1 1-(1h-indol-1-yl)-3-(4-methylpiperazin-1-yl)-1-phenyl propan-2-ol derivatives and related compounds as modulators of the norepinephrine (ne) and the serotonine (5-ht) activity and the monoamine reuptake for the treatment of vasomotor symptoms (vms) |
| 12/20/2006 | EP1732566A2 6-azaindole compound |
| 12/20/2006 | EP1732546A2 Novel pyrrolo (2,3-b)pyridine derivatives, the preparation and the pharmaceutical use thereof in the form of kinase inhibitors |
| 12/20/2006 | EP1732545A1 Tetrahydro-beta-carboline compounds and use thereof |
| 12/20/2006 | EP1732541A2 Cyclic compounds |
| 12/20/2006 | EP1622610B1 1-(2h-pyrazol-3-yl)-3-{4-[1-(benzoyl)-piperidin-4-ylmethyl]-phenyl}-urea derivatives and related compounds as inhibitors of p38 kinase and/or tnf inhibitors for the treatment of inflammations |
| 12/20/2006 | EP1506200B1 Diazabicyclic biaryl derivatives |
| 12/20/2006 | EP1438310B1 Beta-carbolin derivatives as ptp-inhibitors |
| 12/20/2006 | EP1390362B1 Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists |
| 12/20/2006 | EP1305308B1 Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity |
| 12/20/2006 | EP1276720B1 2-acyl indol derivatives and their use as anti-tumour agents |